Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population PDF full book. Access full book title Novel Biomarkers in Heart Failure with Reduced and Preserved Ejection Fraction in the General Population by Simon Lanfermann. Download full books in PDF and EPUB format.
Author: Simon Lanfermann
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Author: Simon Lanfermann
Publisher:
ISBN:
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
Author: Michael Lichtenauer
Publisher: MDPI
ISBN: 3039438832
Category : Medical
Languages : en
Pages : 420
Get Book Here
Book Description
Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this Special Issue, we will provide an overview of the current developments in the field of biomarker research, beginning with research on molecular pathways and cellular communication (e.g., microRNA) up to the clinical use of biomarkers.
Author: Michael Lichtenauer
Publisher:
ISBN: 9783039438846
Category :
Languages : en
Pages : 420
Get Book Here
Book Description
Cardiac biomarkers such as troponins and natiuretic peptides have made a great impact on clinical decision making as well as improving our understanding of molecular mechanisms of different disease conditions. However, the biomarkers that are currently in use do not reflect all the multiple disease pathways that are involved in a broad spectrum of cardiac disease conditions ranging from acute coronary syndrome, to heart failure (and heart failure with preserved ejection fraction, HFpEF), to pulmonary hypertension or arrhythmias. In this Special Issue, we will provide an overview of the current developments in the field of biomarker research, beginning with research on molecular pathways and cellular communication (e.g., microRNA) up to the clinical use of biomarkers.
Author: Isaac Tea Beng Loong
Publisher:
ISBN:
Category :
Languages : en
Pages : 184
Get Book Here
Book Description
Author: Toru Suzuki
Publisher: Elsevier Health Sciences
ISBN: 0323566421
Category : Medical
Languages : en
Pages :
Get Book Here
Book Description
This issue of Heart Failure Clinics, edited by Dr. Toru Suzuki, will cover Biomarkers for Heart Failure, including but not limited to Proenkephalin, B-type and mid-regional pro atrial natriuretic peptides , N-terminal B-type natriuretic peptide, Soluble T2, Adrenomedullin, Copeptin, Non-Coding RNAs, Troponin, Growth differentiation factor (GDF-15) , Galectin-3, Proteomic biomarkers, and Metabolic biomarkers .
Author: Michele Emdin
Publisher: Springer
ISBN: 3319263544
Category : Medical
Languages : en
Pages : 288
Get Book Here
Book Description
This book systematically focuses on central sleep apneas, analyzing their relationship especially with heart failure and discussing recent research results and emerging treatment strategies based on feedback modulation. The opening chapters present historical background information on Cheyne-Stokes respiration (CSR), clarify terminology, and explain the mechanics and chemistry of respiration. Following a description of the physiology of respiration, the pathophysiology underlying central apneas in different disorders and particularly in heart failure is discussed. The similarities and differences of obstructive and central apneas are then considered. The book looks beyond the concept of sleep apnea to daytime CSR and periodic breathing during effort and contrasts the opposing views of CSR as a compensatory phenomenon or as detrimental to the failing heart. The diagnostic tools currently in use for the detection of CSR are thoroughly reviewed, with guidance on interpretation of findings. The book concludes by describing the various forms of treatment that are available for CSR and by explaining how to select patients for treatment.
Author: Johann Bauersachs
Publisher: Springer
ISBN: 3319596594
Category : Medical
Languages : en
Pages : 574
Get Book Here
Book Description
This special issue of the Handbook of Experimental Pharmacology on Heart Failure covers the entire spectrum of the field, from the current understanding and definitions of heart failure, to epidemiology and the importance of co-morbidities, clinical trial design and biomarkers, as well as imaging technologies. The main focus of this book is to review current and emerging heart failure therapies and potential targets for treatment.
Author: Alexandre Mebazaa
Publisher: Springer Science & Business Media
ISBN: 1846287820
Category : Medical
Languages : en
Pages : 922
Get Book Here
Book Description
For many years, there has been a great deal of work done on chronic congestive heart failure while acute heart failure has been considered a difficult to handle and hopeless syndrome. However, in recent years acute heart failure has become a growing area of study and this is the first book to cover extensively the diagnosis and management of this complex condition. The book reflects the considerable amounts of new data reported and many new concepts which have been proposed in the last 3-4 years looking at the epidemiology, diagnostic and treatment of acute heart failure.
Author: Ghousia Begum
Publisher: BoD – Books on Demand
ISBN: 1789236665
Category : Medical
Languages : en
Pages : 250
Get Book Here
Book Description
This book investigates the emerging use of biomarkers as a diagnostic tool for the identification of patients with an abnormal condition or as a tool for staging the extent of disease, as an indicator of disease prognosis. Chapters in Part I focus on biomarkers for cancer, including breast cancer and pancreatic cancer, as well as circulating microRNA profiling in cancer biomarker discovery. Chapters in Part II focus on biomarkers of other diagnoses/diseases, including sepsis, childhood renal diseases, pulmonary diseases, Alzheimer's, leishmaniasis, and heart failure. This book investigates the emerging use of biomarkers as a diagnostic tool for the identification of patients with an abnormal condition or as a tool for staging the extent of disease, as an indicator of diseases prognosis. The book is of considerable importance for a broad range of people including researchers, clinicians, and university students.
Author: Yuli Huang
Publisher: Frontiers Media SA
ISBN: 2832519040
Category : Medical
Languages : en
Pages : 168
Get Book Here
Book Description
